NEUROPACE, INC. Increase (Decrease) in Contract with Customer, Liability
NEUROPACE, INC. (NPCE) reported Increase (Decrease) in Contract with Customer, Liability of -$18.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-11
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$3.00K, a 117.65% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$15.00K, a 112.10% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$507.00K.
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$48.00K.
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was -$414.00K.
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$534.00K, a 148.99% decline from fiscal 2023.
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $1.09M.
- NEUROPACE, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$18.00K 10-Q · filed 2026-08-11 | -$525.00K derived: sum of 3 quarters · filed 2026-08-11 | -$573.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$15.00K 10-Q · filed 2026-05-12 | -$522.00K derived: sum of 2 quarters · filed 2026-05-12 | -$570.00K derived: sum of 3 quarters · filed 2026-05-12 | -$553.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$507.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$555.00K derived: sum of 2 quarters · filed 2026-03-03 | -$538.00K derived: sum of 3 quarters · filed 2026-08-11 | -$414.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$31.00K derived: sum of 2 quarters · filed 2026-08-11 | $93.00K 10-Q · filed 2025-11-04 | -$100.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $141.00K 10-Q · filed 2026-08-11 | -$52.00K derived: sum of 3 quarters · filed 2026-08-11 | -$113.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $124.00K 10-Q · filed 2026-05-12 | -$69.00K derived: sum of 2 quarters · filed 2026-05-12 | -$130.00K derived: sum of 3 quarters · filed 2026-05-12 | -$190.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$254.00K derived: sum of 2 quarters · filed 2026-03-03 | -$314.00K derived: sum of 3 quarters · filed 2026-03-03 | -$534.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$121.00K derived: sum of 2 quarters · filed 2025-11-04 | -$341.00K 10-Q · filed 2025-11-04 | $749.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$280.00K 10-Q · filed 2025-08-12 | $810.00K derived: sum of 3 quarters · filed 2025-08-12 | $810.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$220.00K 10-Q · filed 2025-05-13 | $870.00K derived: sum of 2 quarters · filed 2025-05-13 | $870.00K derived: sum of 3 quarters · filed 2025-05-13 | $870.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.09M derived: sum of 2 quarters · filed 2025-03-04 | $1.09M derived: sum of 3 quarters · filed 2025-03-04 | $1.09M 10-K · filed 2025-03-04 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |